{"id":"https://openalex.org/W2979833294","doi":"https://doi.org/10.1182/blood.v126.23.2484.2484","title":"Systematic Evaluation of Preclinical Genetically Determined Vs. \"Stochastic\"/Transient Resistance to High-Dose Melphalan Treatment in Multiple Myeloma","display_name":"Systematic Evaluation of Preclinical Genetically Determined Vs. \"Stochastic\"/Transient Resistance to High-Dose Melphalan Treatment in Multiple Myeloma","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2979833294","doi":"https://doi.org/10.1182/blood.v126.23.2484.2484","mag":"2979833294"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2484.2484","doi":"https://doi.org/10.1182/blood.v126.23.2484.2484","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2484.2484","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089930630","display_name":"Paul J. Hengeveld","orcid":"https://orcid.org/0000-0002-0070-138X","observed_orcids":["https://orcid.org/0000-0002-0070-138X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL","US"],"is_corresponding":true,"raw_author_name":"Paul J. Hengeveld","raw_affiliation_strings":["Department of Hematology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands","Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023676277","display_name":"Geoffrey M. Matthews","orcid":"https://orcid.org/0000-0002-2804-2021","observed_orcids":["https://orcid.org/0000-0002-2804-2021"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Geoffrey M. Matthews","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039965800","display_name":"Yiguo Hu","orcid":"https://orcid.org/0000-0002-3973-2140","observed_orcids":["https://orcid.org/0000-0002-3973-2140"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yiguo Hu","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023112790","display_name":"Michal Sheffer","orcid":"https://orcid.org/0000-0001-5934-9950","observed_orcids":["https://orcid.org/0000-0001-5934-9950"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michal Sheffer","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108696080","display_name":"Megan A. Bariteau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Megan A. Bariteau","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060982277","display_name":"Haley Poarch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Haley I. Poarch","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074250265","display_name":"Eugen Dhimolea","orcid":"https://orcid.org/0000-0002-8445-5509","observed_orcids":["https://orcid.org/0000-0002-8445-5509"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eugen Dhimolea","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantine S Mitsiades","raw_affiliation_strings":["Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5023112790","https://openalex.org/A5023676277","https://openalex.org/A5060982277","https://openalex.org/A5074250265","https://openalex.org/A5089930630","https://openalex.org/A5108696080"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2802928900","https://openalex.org/I4210117453","https://openalex.org/I887064364"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38825226,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"2484","last_page":"2484"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/high-dose-melphalan","display_name":"high-dose melphalan","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6909999847412109},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/lentiviral-transduction","display_name":"lentiviral transduction","score":0.6830000281333923},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5400000214576721},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.38199999928474426},{"id":"https://openalex.org/keywords/single-guide-rna","display_name":"single guide RNA","score":0.3100000023841858},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.7212256193161011},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6616146564483643},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.47986453771591187},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.47887223958969116},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4517946243286133},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.44006454944610596},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4256399869918823},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.41954925656318665},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3867718279361725},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3866797685623169},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3443344831466675},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25438034534454346},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20429742336273193},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2034398913383484}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2484.2484","doi":"https://doi.org/10.1182/blood.v126.23.2484.2484","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2484.2484","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2581533094","https://openalex.org/W3095991104","https://openalex.org/W2197777720","https://openalex.org/W4313549658","https://openalex.org/W2974966304","https://openalex.org/W4393073498","https://openalex.org/W101918116","https://openalex.org/W2255357581","https://openalex.org/W2417729128","https://openalex.org/W2907716952"],"abstract_inverted_index":{"Abstract":[0],"Myeloablative":[1],"high-dose":[2],"melphalan":[3,32,297,309,496,602],"(HDM)":[4],"followed":[5],"by":[6,250],"autologous":[7,279],"stem":[8,68],"cell":[9,57,69,193,340,372,484,492,552,595],"transplantation":[10],"(ASCT)":[11],"remains":[12],"one":[13],"of":[14,17,55,71,83,96,124,130,160,181,209,219,244,246,261,272,293,296,308,346,359,408,433,440,495,505,525,533,547,555,569,593,600,611,618,631,635],"the":[15,27,38,48,64,72,80,107,122,127,149,173,190,201,210,247,251,258,270,278,313,318,328,337,355,406,420,437,469,499,516,526,544,551,567,598,616,629],"cornerstones":[16],"multiple":[18],"myeloma":[19,192],"(MM)":[20],"treatment.":[21],"Conceptually,":[22],"HDM":[23,100,114,170,276,361,416,506,534],"is":[24,41,86,607],"based":[25],"on":[26,335,481,488,581,609],"notion":[28],"that":[29,502,537,562],"a":[30,44,89,344,430,489,522,531],"single":[31,222],"dose":[33,49,292],"(typically":[34],"200":[35],"mg/m2)":[36],"exceeding":[37],"myelotoxicity":[39],"threshold":[40],"associated":[42,166],"with":[43,126,167,197,205,312,332,362,419,451,459,468,590,615],"steep":[45],"increase":[46],"in":[47,79,115,148,277,285,317,356,370,374,380,475,550,571,628],"response":[50],"curve":[51],"and":[52,101,171,204,232,241,298,339,385,403,536,573,585],"higher":[53],"degree":[54,174],"MM":[56,97,116,161,262,273,371,410,483,491,527,594,619],"killing":[58],"compared":[59],"to":[60,103,113,169,175,184,239,256,265,275,288,304,392,412,415,435,448,565,597,621,625],"fractionated":[61],"delivery":[62],"(without":[63],"need":[65],"for":[66,111,121,200],"hematopoietic":[67],"support)":[70],"same":[73],"cumulative":[74],"dose.":[75],"Despite":[76],"its":[77],"importance":[78],"therapeutic":[81],"management":[82],"MM,":[84],"HDM-ASCT":[85,570],"not":[87,464,578],"considered":[88],"curative":[90],"procedure,":[91],"presumably":[92],"because":[93],"chemoresistant":[94],"subpopulations":[95],"cells":[98,162,263,274,350,378,389,411,443,461,528,620],"survive":[99,530],"lead":[102],"eventual":[104],"relapse.":[105],"Elucidating":[106],"molecular":[108],"mechanisms":[109,140,180,541,634],"responsible":[110],"resistance":[112,139,168,182,624],"could":[117,163],"have":[118],"major":[119,131],"implications":[120],"identification":[123,610],"patients":[125,572],"highest":[128],"probability":[129],"clinical":[132,319,360],"benefit":[133],"from":[134,382,587],"this":[135,146,185,236,560],"procedure.":[136],"However,":[137],"these":[138,409,441,479,486],"remain":[141],"incompletely":[142],"understood.":[143],"To":[144,267],"address":[145],"void":[147],"field,":[150],"we":[151,188,254,282],"examined":[152],"whether":[153],"an":[154,290,510],"open-ended":[155],"unbiased":[156,511],"genome-wide":[157,329,421],"functional":[158,612],"characterization":[159],"uncover":[164],"genes":[165,231,248],"quantify":[172,393],"which":[176,217,462,529],"other,":[177],"non-genetically":[178,539],"determined,":[179],"contribute":[183],"process.":[186],"Specifically,":[187],"used":[189],"human":[191],"line":[194,493],"MM1.S,":[195],"transduced":[196,467],"lentiviral":[198,207],"construct":[199],"Cas9":[202],"nuclease":[203],"pooled":[206,221],"particles":[208],"GeCKO":[211],"library":[212],"(Shalem":[213],"et":[214,322],"al.,":[215,323],"2014),":[216],"consists":[218],"2":[220],"guide":[223],"RNA":[224],"(sgRNA)":[225],"sub-libraries":[226],"(~120,000":[227],"sgRNAs;":[228],"targeting":[229],"~19,000":[230],"~1800":[233],"miRNAs).":[234],"Using":[235],"CRISPR/Cas9-based":[237],"approach":[238],"mutagenize":[240],"cause":[242],"loss":[243],"function":[245],"recognized":[249],"respective":[252],"sgRNAs,":[253],"sought":[255],"facilitate":[257],"prospective":[259],"isolation":[260],"resistant":[264],"HDM.":[266,452],"better":[268],"simulate":[269],"exposure":[271,414,434,596],"transplant":[280],"setting,":[281],"adapted":[283],"our":[284,363,476,556],"vitro":[286,357],"treatment":[287,450],"include":[289],"initial":[291],"25":[294],"\u00b5M":[295],"sequential":[299],"one-hour":[300],"interval":[301],"partial":[302],"wash-outs,":[303],"achieve":[305],"gradual":[306],"reduction":[307,369],"concentrations,":[310],"consistent":[311,418],"pharmacokinetic":[314],"profile":[315],"observed":[316,425],"setting":[320],"(Nath":[321],"2010).":[324],"We":[325,424],"repeated":[326,591],"twice":[327],"knock-out":[330],"screens,":[331,376],"biological":[333,384],"replicates":[334],"both":[336,375],"transduction":[338],"culture":[341],"level":[342],"(maintaining":[343],"coverage":[345],"at":[347],"least":[348],"1000":[349],"per":[351],"individual":[352],"sgRNA).":[353],"While":[354,472],"simulation":[358],"wash-out":[364],"regimen":[365],"achieved":[366],">99%":[367],"estimated":[368],"viability":[373],"viable":[377],"re-emerged":[379],"cultures":[381],"all":[383],"technical":[386],"replicates.":[387],"HDM-resistant":[388],"were":[390,444],"processed":[391],"their":[394,574],"sgRNA":[395,470],"enrichment":[396],"or":[397],"depletion,":[398],"using":[399],"next":[400],"generation":[401],"sequencing,":[402],"also":[404,457],"characterize":[405],"sensitivity":[407],"repeat":[413,449],"concentrations":[417],"CRISPR":[422],"screens.":[423],"that,":[426],"despite":[427],"having":[428],"survived":[429],"previous":[431],"round":[432,532],"HDM,":[436,626],"majority":[438],"(>90%)":[439],"sgRNA-transduced":[442],"again":[445],"highly":[446],"responsive":[447],"A":[453],"similar":[454],"result":[455],"was":[456],"obtained":[458],"MM1.S":[460],"had":[463],"been":[465],"previously":[466],"sub-libraries.":[471],"ongoing":[473],"investigation":[474],"lab":[477],"addresses":[478],"findings":[480],"additional":[482],"lines,":[485],"observations":[487],"well-established":[490],"model":[494],"responsiveness":[497],"raises":[498],"intriguing":[500],"possibility":[501],"genetically-determined":[503,633],"forms":[504],"resistance,":[507,548],"conferred":[508],"after":[509],"genome":[512],"scale":[513],"evaluation":[514],"through":[515],"CRISPR/Cas9-editing":[517],"methodology,":[518],"may":[519,542],"only":[520],"represent":[521],"small":[523],"fraction":[524],"treatment,":[535],"other":[538],"determined":[540],"mediate":[543],"principal":[545],"mode":[546],"even":[549,627],"autonomous":[553],"context":[554],"experiments.":[557],"In":[558],"turn,":[559],"suggests":[561],"future":[563],"efforts":[564],"individualize":[566],"administration":[568],"post-ASCT":[575],"monitoring":[576],"should":[577],"rely":[579],"exclusively":[580],"genetic":[582],"markers":[583,613],"identified":[584],"validated":[586],"preclinical":[588],"experimentation":[589],"rounds":[592],"equivalent":[599],"myelotoxic":[601],"concentrations.":[603],"Instead,":[604],"renewed":[605],"emphasis":[606],"warranted":[608],"correlating":[614],"ability":[617],"develop":[622],"transient":[623],"absence":[630],"constitutive":[632],"resistance.":[636],"Disclosures":[637],"Mitsiades:":[638],"Novartis:":[639],"Research":[640,643,648],"Funding;":[641,644],"TEVA:":[642],"Janssen/Johnson":[645],"&":[646],"Johnson:":[647],"Funding.":[649]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-10-18T00:00:00"}